Q3 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
No data found for this quarter. | ||||||
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Get more info on our International short position coverage here
Holder | Issuer | Net Short Position | Position Date | Origin |
---|
Updated daily
Contains transactions from January 1st, 2015 on. This data is
Form | Holder | Issuer | Transaction Date | Number of Voting Rights | % of Voting Rights |
---|---|---|---|---|---|
TR-1 | GIC Private Limited | ConvaTec Group Plc | 2020-10-28 | 0 | 0.0% |
TR-1 | Black Creek Investment Management Inc. | ConvaTec Group PLC | 2020-10-08 | 80,048,681 | 4.0% |
TR-1 | Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios | ConvaTec Group Plc | 2020-10-01 | 0 | 0.0% |
TR-1 | GIC Private Limited | ConvaTec Group Plc | 2020-08-06 | 60,078,229 | 3.003% |
TR-1 | Black Creek Investment Management Inc. | ConvaTec Group PLC | 2020-06-05 | 60,148,404 | 3.01% |
TR-1 | The Goldman Sachs Group, Inc. | ConvaTec Group Plc | 2017-06-09 | 0 | 0% |
TR-1 | NORDIC CAPITAL VI LIMITED NORDIC CAPITAL VII LIMITED | CONVATEC GROUP PLC | 2017-06-08 | 143,158,828 | 7.34% |
TR-1 | ACP CONVATEC, LLC | CONVATEC GROUP PLC | 2017-06-08 | 58,244,619 | 2.98% |
TR-1 | The Goldman Sachs Group, Inc. | ConvaTec Group Plc | 2017-06-08 | 60,795,414 | 3.12% |
NORDIC CAPITAL VI LIMITED NORDIC CAPITAL VII LIMITED | CONVATEC GROUP PLC | 2017-03-31 | 314,158,828 | 16.1% | |
Novo Nordisk Foundation | ConvaTec Group Plc | 2017-03-31 | 389,318,793 | 19.95% | |
Holdings in Company | ACP CONVATEC, LLC | CONVATEC GROUP PLC | 2016-11-29 | 366,540,257 | 18.8% |
Holdings in Company | AVISTA CAPITAL PARTNERS II, LP | CONVATEC GROUP PLC | 2016-11-29 | 0 | 0% |
Holdings in Company | AVISTA CAPITAL PARTNERS, LP | CONVATEC GROUP PLC | 2016-11-29 | 0 | 0% |
Holdings in Company | ACP CONVATEC COINVEST, LLC | CONVATEC GROUP PLC | 2016-11-29 | 0 | 0% |
TR-1 | The Capital Group Companies, Inc. | ConvaTec Group plc | 2016-11-04 | 99,839,000 | 5.116% |
TR-1 | OrbiMed Advisors LLC and OrbiMed Capital LLC | ConvaTec Group PLC | 2016-10-26 | 23,000,000 | 3.49% |
TR-1 | OrbiMed Advisors LLC and OrbiMed Capital LLC | ConvaTec Group PLC | 2016-10-26 | 23,000,000 | 1.18% |
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | CONVATEC GROUP PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | CONVATEC GROUP PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | CONVATEC GROUP PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group Plc | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% | ||
Holdings in Company | ConvaTec Group PLC | 0 | 0% |